DiAnna L. Hynds

DiAnna L. Hynds

Auto-generated profile, based on publicly available information

DiAnna L. Hynds


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2002 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
WJWilliam E. B. Johnson
William E. B. Johnson
BCBruce Caterson
Bruce Caterson
SEStephen M. Eisenstein
Stephen M. Eisenstein
DHDianna L. Hynds
Dianna L. Hynds
DSDiane M. Snow
Diane M. Snow
SRSally Roberts
Sally Roberts
Objective: To assess the effects of human intervertebral disc aggrecan on nerve growth and guidance, using in vitro techniques.Methods: Aggrecan extracted from human lumbar intervertebral discs was incorporated into tissue culture substrata for the culture of the human neuronal cell line, SH‐SY5Y, or explants of chick dorsal root ganglia. The effects on nerve growth of different concentrations of aggrecan extracted from the anulus fibrosus and nucleus pulposus, and of these aggrecan preparations following enzymic deglycosylation, were compared.Results: Disc aggrecan inhibited the growth of neurites from SH‐SY5Y cells and induced growth cone turning of chick sensory neurites in a concentration‐dependent manner. Aggrecan isolated from the anulus fibrosus was more inhibitory than that isolated from the nucleus pulposus, but enzymic pretreatments to reduce the glycosylation of both types of disc aggrecan partially abrogated their inhibitory effects.Conclusion: Nerve growth into degenerate intervertebral discs has been linked with the development of low back pain, but little is known about factors affecting disc innervation. The finding that disc aggrecan inhibits nerve growth in vitro, and that this inhibitory activity depends on aggrecan glycosylation, has important implications for our understanding of mechanisms that may regulate disc innervation in health and disease.


1 November 1999 in Experimental Neurology
Verified
Journal Article
Closed access
DHDiAnna L. Hynds
DiAnna L. Hynds
DSDiane M. Snow
Diane M. Snow

28 September 2010 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
FSFilsy Samuel
Filsy Samuel
DHDiAnna L. Hynds
DiAnna L. Hynds

23 November 1995 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
DHDiAnna L. Hynds
DiAnna L. Hynds
MSMonica Summers
Monica Summers
JBJames Van Brocklyn
James Van Brocklyn
MOM. Sue O'DOrisio
M. Sue O'DOrisio
AYAllan J. Yates
Allan J. Yates

15 May 2003 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
DHDiAnna L. Hynds
DiAnna L. Hynds
MSMike L. Spencer
Mike L. Spencer
DADouglas A. Andres
Douglas A. Andres
DSDiane M. Snow
Diane M. Snow
Rit, by sequence homology, is a member of the Ras subfamily of small guanine triphosphatases (GTPases). In PC6 cells, Rit signals through pathways both common to and different from those activated by Ras to promote cell survival and neurite outgrowth. However, the specific morphological changes induced by Rit in human cells are not known. Here, we show in a human neuronal model that Rit increases neurite outgrowth and branching through MEK-dependent and MEK-independent signaling mechanisms, respectively. Adenoviral expression of wild-type or constitutively active Rit increased neurite initiation,elongation and branching on endogenous matrix or a purified laminin-1 substratum of SH-SY5Y cells as assessed using image analysis. This outgrowth was morphologically distinct from that promoted by constitutively active Ras or Raf (evidenced by increased branching and elongation). Constitutively active Rit increased phosphorylation of ERK 1/2, but not Akt, and the MEK inhibitor PD 098059 blocked constitutively active Rit-induced neurite initiation but not elongation or branching. These results suggest that Rit plays a key role in human neuronal development and regeneration through activating both known and as yet undefined signaling pathways.